Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art
- PMID: 28915901
- PMCID: PMC5603037
- DOI: 10.1186/s13052-017-0402-8
Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art
Abstract
Growth hormone deficiency (GHD) is a relatively uncommon and heterogeneous endocrine disorder presenting in childhood with short stature. However, during the neonatal period, the metabolic effects of GHD may to require prompt replacement therapy to avoid possible life-threatening complications. An increasing amount of data suggests the importance of an early diagnosis and treatment of GHD because of its auxological, metabolic, and neurodevelopmental features with respect to the patients diagnosed and treated later in life.The available results show favourable auxological outcomes for patients with GHD diagnosed and treated with r-hGH early in life compared with those from patients with GHD who do not receive this early diagnosis and treatment. Because delayed referral for GHD diagnosis and treatment is still frequent, these results highlight the need for more attention in the diagnosis and treatment of GHD.Despite these very encouraging data regarding metabolic and neurodevelopmental features, further studies are needed to better characterize these findings. Overall, the importance of early diagnosis and treatment of GHD needs to be addressed.
Keywords: Adult height; Brain; Dwarfism; Early diagnosis; Early treatment; Growth hormone; Growth hormone deficiency; Height; Hormone replacement therapy; Metabolism.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Growth hormone and early treatment.Minerva Endocrinol. 2015 Jun;40(2):129-43. Minerva Endocrinol. 2015. PMID: 25734895 Review.
-
Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.J Clin Endocrinol Metab. 2006 Nov;91(11):4271-6. doi: 10.1210/jc.2006-0383. Epub 2006 Aug 15. J Clin Endocrinol Metab. 2006. PMID: 16912138 Clinical Trial.
-
Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from Turkey.J Clin Res Pediatr Endocrinol. 2015 Mar;7(1):37-44. doi: 10.4274/jcrpe.1794. J Clin Res Pediatr Endocrinol. 2015. PMID: 25800474 Free PMC article.
-
Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?J Pediatr Endocrinol Metab. 2012;25(7-8):651-7. doi: 10.1515/jpem-2012-0182. J Pediatr Endocrinol Metab. 2012. PMID: 23155689
-
Controversies in the definition and treatment of idiopathic short stature (ISS).J Clin Res Pediatr Endocrinol. 2009;1(3):105-15. doi: 10.4008/jcrpe.v1i3.53. Epub 2009 Feb 1. J Clin Res Pediatr Endocrinol. 2009. PMID: 21274395 Free PMC article. Review.
Cited by
-
Management of Neonatal Isolated and Combined Growth Hormone Deficiency: Current Status.Int J Mol Sci. 2023 Jun 14;24(12):10114. doi: 10.3390/ijms241210114. Int J Mol Sci. 2023. PMID: 37373261 Free PMC article. Review.
-
Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB).Pharmacoecon Open. 2023 Jan;7(1):121-138. doi: 10.1007/s41669-022-00373-z. Epub 2022 Oct 18. Pharmacoecon Open. 2023. PMID: 36255609 Free PMC article.
-
Persistence to growth hormone treatment and clinical characteristics of pediatric patients with growth hormone deficiency: A retrospective cohort study of data from the Japan Medical Data Center claims database.Endocr J. 2025 May 7;72(5):475-485. doi: 10.1507/endocrj.EJ24-0225. Epub 2025 Feb 20. Endocr J. 2025. PMID: 39971283 Free PMC article.
-
Growth hormone deficiency and replacement in children.Rev Endocr Metab Disord. 2021 Mar;22(1):101-108. doi: 10.1007/s11154-020-09604-2. Epub 2020 Oct 8. Rev Endocr Metab Disord. 2021. PMID: 33029711 Review.
-
[Early diagnosis and intervention for prepubertal short stature children].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jun 15;26(6):553-558. doi: 10.7499/j.issn.1008-8830.2312103. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 38926370 Free PMC article. Review. Chinese.
References
-
- Growth Hormone Research Society Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab. 2000;85:3990–3993. - PubMed
-
- National Institute for Health and Care Excellence. TA188. Human growth hormone (somatropin) for the treatment of growth failure in children: guidance. May 2013. [Internet]. Available from: https://www.nice.org.uk/guidance/ta188. [cited 2016, April 26].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical